24.01.2012
The War Continues - The European Union's Falsified Medicines directive, ratified in 2011, was arguably the most significant landmark to date in the war on fake drugs.
The law will require (from around 2016) a traceable safety feature and tamper evident closure on almost all prescription medical products sold in the EU. Mark Davison, CEO of Blue Sphere Health, examines some of the approaches his customers are using to comply with the directive and other legal obligations around the world.
more19.10.2011
Protection - The seamless documentation of supply chains and the ruling out of counterfeit products as far as possible are measures that serve to protect producers as well as patients.
These functions are assigned to one- and two-dimensional codes with which pharmaceutical manufacturers in an increasing number of countries are legally required to mark their products. However, that is just one step.
Such an identification system must function across national borders and be adaptable to meet local requirements.
more14.09.2010
A Real Solution - An environmental revolution is underway that will impact communities, governments and businesses across the globe. Conservation and management of finite resources are at stake as we address the "perfect storm" of rising energy prices, societal and customer expectations to go green.
The healthcare industry is no exception, and packaging will play a key role in providing solutions, as it represents upwards of 30-50% of the overall waste stream.
more09.09.2010
Safety First - France is adopting the Datamatrix system to meet new regulations on the traceability of pharmaceutical products to increase patient safety. Avery Dennison is at the forefront of the Datamatrix barcoding technology that will become the accepted standard across France in January 2011. Other European states, such as the UK, Germany, Spain and Italy are looking to introduce similar regulations to improve consumer safety. 2D Datamatrix barcodes are able to store large amounts of information (up to 2,300 alphanumeric characters) on a small label.
more22.07.2010
The seemingly humble blister pack is the standard unit of primary pharmaceutical packaging in both Europe and most of the world. It is the critical means of ensuring the pharma dosage is protected against all potential degradents and is presented to the patient in the correct manner in compliance with their medication regime. It is, in fact, a sophisticated drug delivery system in its own right and has a number of critical functions to fulfil.
more21.04.2010
Being Attentive - When it comes to packaging sterile medical supplies, particularly stringent quality and safety regulations apply. To begin with, the labels have to be country-specific and language-specific, which requires a considerable amount of effort, and mistakes are even less tolerable than anywhere else. Fulfilling these wide-ranging technical packaging demands requires flexibility and stable controls in the packaging line.
more20.04.2010
Solving Challenges - Due to smaller production volumes, lines used to produce drugs for clinical trial operations have always had distinct needs in terms of processing equipment. Additionally, a number of industry trends are changing the drug development landscape, and these changes are having important effects on clinical trial and pilot drug production.
more14.04.2010
Fighting Piracy - Over the past couple of years, there have been many ongoing discussions throughout the world on how to combat the problems of counterfeiting in the pharmaceutical industry. Several solutions have been developed and applied, e.g. hologram labels, tamper-evident labeling as well as many others. In addition to these familiar technologies, many governments worldwide have passed legislation requiring the unique marking of each individual unit of sale.
more